Verve Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare…
<!-- Name:DistributionId Value:8795265 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Guggenheim
Cullinan Oncology to Participate in the Guggenheim 5th Annual Oncology Conference and…
<!-- Name:DistributionId Value:8742071 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Guggenheim Partners financier Scott Minerd dies aged 63
Scott Minerd, the global chief investment officer at Guggenheim Partners, has died after suffering a heart attack during a regular workout, the Chicago based financial firm announced…
Axsome Therapeutics to Present at the Guggenheim 4th Annual Immunology and Neurology…
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central…
Xilio Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference
WALTHAM, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-selective immuno-oncology therapies for people living…
Cue Biopharma to Present at the Guggenheim I&I Spotlight Series
BOSTON, July 11, 2022 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively…
Director of the Guggenheim to Step Down
Richard Armstrong, the director of the Solomon R. Guggenheim Museum, said he planned to retire from his role next year, capping off more than 14 years leading the institution and its…
A Conceptual ‘Queer’ Club at the Guggenheim
New York’s hottest club is Guggenheim. It has everything: trans performers named after cocktails, live puppets, business executives and fashion plates who wear dresses made from human hair…
Guggenheim Removes Sackler Name Over Ties to Opioid Crisis
The Solomon R. Guggenheim Museum quietly distanced itself from the Sacklers last week, erasing the family’s name from an education center over the family’s ties to the opioid crisis. There…
Krystal Biotech to Participate in H.C. Wainwright and Guggenheim Investor Conferences
PITTSBURGH, March 24, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapy, today announced that Krish S. Krishnan, Chairman…